Muscle Relaxant Drugs Market Business Strategies, and Regional Outlook
Today, the population of people aged 60 years or above is growing much faster than it was a few years back. As per the World Health Organization (WHO), the proportion of aged people will nearly double from 12% in 2015 to 22% in 2050. Owing to this, the medical settings need to be prepared for catering to the needs of this age group, since the geriatric population is more susceptible to diseases and therefore requires frequent and effective care. As a person grows older, their bodily functions start needing much more care. The physical body becomes weaker, which is why older people are also more prone to muscle spasms and body pain.
Because of this, the demand for muscle relaxants is growing at a swift pace. Muscle relaxants are utilized for preventing and reducing muscle spasms and tightness, which may occur due to an uncontrolled contraction of muscles. The muscle contract sudden resulting in pain, which creates the need for medical intervention. Ascribed to these factors, the global muscle relaxant drugs market is projected to grow at a rapid pace in the coming years. The three major types of muscle relaxants are neuromuscular blocking agents, facial aesthetic relaxants, and skeletal muscle relaxants.
Out of these, the demand for facial aesthetic relaxants was the highest in the past, which is basically because of the high safety and efficiency of these drugs. Different types of facial aesthetic relaxant drugs are dysport and Botox, between which, the demand for Botox was higher in the past. Other than this, the demand for skeletal muscle relaxants is also expected to rise in the near future. Antispastic and antispasmodic are two types of skeletal muscle relaxants. Antispastic agents are utilized for conditions such as multiple sclerosis and cerebral palsy and antispasmodic agents are used for the management of musculoskeletal conditions such as neck pain, tension headaches, and lower back pain.
Owing to the growing utilization of facial muscle relaxants and surging geriatric population, North America has been a major consumer of muscle relaxants in the past. Furthermore, increasing research & development investments, rising awareness regarding musculoskeletal problems and their management, and advancements in healthcare infrastructure are also driving the demand for muscle relaxants in the region. Apart from this, the Asian region is predicted to emerge as the fastest-growing muscle relaxant drugs market in the coming years, which is due to the rising prevalence of chronic diseases, increasing number of surgeries, and surging geriatric population.
Hence, the demand for muscle relaxant drugs is also growing due to the rising geriatric population and increasing incidence of skin diseases around the globe.
Browse detailed report on Muscle Relaxant Drugs Market Size, and Business Strategies